PINC gene delivery systems - Valentis
Latest Information Update: 21 May 2007
At a glance
- Originator Valentis
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Unspecified
Most Recent Events
- 24 Apr 2007 This technology is available for sale or licensing (http://www.valentis.com)
- 13 Apr 2000 New profile
- 13 Apr 2000 Phase-II clinical trials for Undefined in USA (Injection)